Core Viewpoint - The A-share market saw a collective rise in its three major indices, with the Shanghai Composite Index reaching a ten-year high, driven by strong performance in the brain-computer interface sector [1] Group 1: Market Performance - On January 6, the A-share market indices collectively rose, with the Shanghai Composite Index opening high and continuing to climb [1] - The brain-computer interface concept stocks maintained strong momentum, with companies like Beikang and Sanbo Brain Science hitting their daily price limits [1] Group 2: Company Developments - Elon Musk announced via social media that his company Neuralink plans to start large-scale production of brain-computer interface devices by December 31, 2026, and will advance nearly fully automated surgical procedures [1] - Merge Labs, a startup co-founded by OpenAI CEO Sam Altman, announced its spin-off to focus on non-invasive brain signal reading technology using ultrasound, aiming for broader and more precise interpretation without electrode implantation [1] Group 3: Industry Insights - According to a report by Guokai Securities, brain-computer interfaces are at the forefront of artificial intelligence technology and are expected to accelerate applications in medical, mental health, rehabilitation, and health management sectors with policy support [1] - Since 2025, both domestic and international AI technologies, products, and commercial applications have rapidly developed, with the pharmaceutical industry being a key application area, indicating significant potential for AI in drug development, auxiliary diagnosis, and services [1]
继续涨!脑机接口概念再掀涨停潮,三博脑科连续“20cm”封板